ArticleAllergy2020

Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry.

Lotte S Spekhorst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.